Emerging Frontiers in Antioxidant Therapeutics: From Nanotechnology-Enabled Delivery to Mitochondria-Targeted Interventions
Science and Technology Nexus · 2026
DOI: 10.25259/stn_19_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science and Technology Nexus, 2026. Verfasst von Lina M. Shaker und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate emerging strategies in antioxidant therapy addressing the limitations of traditional antioxidants in managing oxidative stress-related chronic diseases. Material and Methods This review analyses literature on antioxidant delivery enhancements through anotechnology, including liposomes, nanoparticles, and stimuli-responsive nanocarriers, and examines mitochondrial-targeted agents and phytochemicals.
Results
Findings highlight the poor bioavailability and targeting of traditional antioxidants such as vitamins C, E, and flavonoids. Novel delivery systems improve antioxidant stability and site-specific release. Mitochondria-targeting agents (MitoQ, SS-31, SkQ1) show clinical promise. Phytochemicals like curcumin and resveratrol exhibit improved efficacy when delivered via nanocarriers.
Conclusion
Advances in nanocarrier engineering, mitochondrial targeting, and activation of endogenous pathways (e.g., Nrf2) define a new era of precision redox medicine, enhancing antioxidant therapy’s therapeutic potential.
Zitieren
APA
Shaker, L. M., & Al-Amiery, A. A. (2026). Emerging Frontiers in Antioxidant Therapeutics: From Nanotechnology-Enabled Delivery to Mitochondria-Targeted Interventions. Science and Technology Nexus. https://doi.org/10.25259/stn_19_2025
Vancouver
Shaker LM, Al-Amiery AA. Emerging Frontiers in Antioxidant Therapeutics: From Nanotechnology-Enabled Delivery to Mitochondria-Targeted Interventions. Science and Technology Nexus. 2026. doi:10.25259/stn_19_2025
BibTeX
@article{Shaker2026,
author = {Shaker, Lina M. and Al-Amiery, A. A.Hussain},
title = {Emerging Frontiers in Antioxidant Therapeutics: From Nanotechnology-Enabled Delivery to Mitochondria-Targeted Interventions},
journal = {Science and Technology Nexus},
year = {2026},
doi = {10.25259/stn_19_2025}
}
EUVIMED